Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

  1. Cortes, J.
  2. Hudgens, S.
  3. Twelves, C.
  4. Perez, E.A.
  5. Awada, A.
  6. Yelle, L.
  7. McCutcheon, S.
  8. Kaufman, P.A.
  9. Forsythe, A.
  10. Velikova, G.
Aldizkaria:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Argitalpen urtea: 2015

Alea: 154

Zenbakia: 3

Orrialdeak: 509-520

Mota: Artikulua

DOI: 10.1007/S10549-015-3633-7 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus